Mergers & Acquisitions
Fulgent Genetics
04/22
|
$170.0 Million
Âé¶¹´«Ã½ served as buy-side advisor for Fulgent Genetics on acquisition of Inform Diagnostics, a portfolio company of Avista Capital Partners
Sub-Type
Buy-Side
Sector
Sub-Sector
Life Sciences Tools & Diagnostics